Jennifer Stephens

4.2k total citations · 1 hit paper
112 papers, 3.1k citations indexed

About

Jennifer Stephens is a scholar working on Infectious Diseases, Epidemiology and Hematology. According to data from OpenAlex, Jennifer Stephens has authored 112 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Infectious Diseases, 20 papers in Epidemiology and 19 papers in Hematology. Recurrent topics in Jennifer Stephens's work include Antimicrobial Resistance in Staphylococcus (18 papers), Antibiotic Use and Resistance (13 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Jennifer Stephens is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (18 papers), Antibiotic Use and Resistance (13 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Jennifer Stephens collaborates with scholars based in United States, United Kingdom and France. Jennifer Stephens's co-authors include Marc Botteman, Dilip Nathwani, Claudie Charbonneau, Sajjad Haider, Chris L. Pashos, Della Varghese, Stéphan Martin, Wajeeha Ansari, Ahmed Shelbaya and Catherine E. Cooke and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jennifer Stephens

105 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review

2019 286 citations Dilip Nathwani, Jennifer Stephens et al. profile →

Peers

Countries citing papers authored by Jennifer Stephens

Since Specialization

Citations

This map shows the geographic impact of Jennifer Stephens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Stephens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Stephens more than expected).

Fields of papers citing papers by Jennifer Stephens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Stephens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Stephens. The network helps show where Jennifer Stephens may publish in the future.

Co-authorship network of co-authors of Jennifer Stephens

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Stephens. A scholar is included among the top collaborators of Jennifer Stephens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Stephens. Jennifer Stephens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Variant Transthyretin Amyloid Cardiomyopathy 2024 ·Cardiology and Therapy ·(unknown), Leslie Amass, Rong Wang, Jennifer Stephens, (unknown), (unknown), (unknown), Farooq H. Sheikh	0
2	Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: An Integrative Literature Review 2024 ·ClinicoEconomics and Outcomes Research ·(unknown), (unknown), Jennifer Stephens, (unknown), Joshua A. Roth, Ahmed Shelbaya	1
3	Factors Influencing Self-Medication Among Students of University of Ghana, Legon 2022 ·(unknown), Jennifer Stephens, Benedict Calys‐Tagoe, Ernest Kenu	3
4	Real-World Cost–Effectiveness of Primary Prophylaxis with G-CSF Biosimilars in Patients at Intermediate/High Risk of Febrile Neutropenia 2022 ·Future Oncology ·Paul Cornes, (unknown), (unknown), (unknown), Jennifer Stephens, Jingyan Yang	2
5	Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world data 2021 ·Journal of Medical Economics ·Jingyan Yang, (unknown), (unknown), (unknown), Jennifer Stephens	5
6	PRO6 Clinical and Ambulatory Characteristics in Adult Patients with Spinal Muscular Atrophy: A Natural History Multi-Country Chart Review Study 2021 ·Value in Health ·Nicole B. Johnson, Angela D. Paradis, Viral Dave, Cynthia Macahilig, (unknown), Jennifer Stephens, Carrie Atzinger	1
7	<p>Cost-Minimization Analysis of Dexmedetomidine Compared to Other Sedatives for Short-Term Sedation During Mechanical Ventilation in the United States</p> 2020 ·ClinicoEconomics and Outcomes Research ·(unknown), (unknown), Jennifer Stephens, (unknown), (unknown)	12
8	Economic and humanistic burden associated with noncommunicable diseases among adults with depression and anxiety in the United States 2020 ·Journal of Medical Economics ·Eric S. Armbrecht, (unknown), (unknown), Ruchit Shah, Elizabeth Pappadopulos, Richard Chambers, Jennifer Stephens, Seema Haider, Roger S. McIntyre	32
9	Early switch/early discharge opportunities for hospitalized patients with methicillin resistant Staphylococcus aureus complicated skin and soft tissue infections: Saudi Arabia and United Arab Emirates 2020 ·Journal of Infection and Public Health ·Ashraf El Houfi, (unknown), Thamer H. Alenazi, Fayssal Farahat, Caitlyn T. Solem, Jennifer Stephens, Courtney Johnson, Cynthia Macahilig, (unknown), Seema Haider	2
10	Abemaciclib Is Active in Preclinical Models of Ewing Sarcoma via Multipronged Regulation of Cell Cycle, DNA Methylation, and Interferon Pathway Signaling 2018 ·Clinical Cancer Research ·Michele Dowless, Caitlin D. Lowery, Terry J. Shackleford, (unknown), Jennifer Stephens, (unknown), Wayne Blosser, Simone Gupta, Julie Stewart, Yue Webster, Jack Dempsey, (unknown), Philip J. Ebert, Philip W. Iversen, Jonathan B. Olsen, Xueqian Gong, Sean G. Buchanan, Peter J. Houghton, Louis F. Stancato	47
11	Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico 2018 ·ClinicoEconomics and Outcomes Research ·Rayo Morfín‐Otero, Martha Alvarado‐Ibarra, Eduardo Rodríguez-Noriega, (unknown), (unknown), Jennifer Stephens, Manuela Di Fusco, (unknown), Claudie Charbonneau	2
12	Clinical, economic, and humanistic burden of needlestick injuries in healthcare workers 2017 ·Medical Devices Evidence and Research ·Catherine E. Cooke, Jennifer Stephens	90
13	Generic Switch Evaluation of Celebrex® In Patients With Osteoarthritis (OA) Using A Retrospective Claims Database 2015 ·Value in Health ·Xiaomeng Ji, (unknown), Caitlyn T. Solem, Ahmed Shelbaya, Chris Walker, Joseph C. Cappelleri, Xiaopan Gao, Jennifer Stephens	1
14	Burden of Nonnucleoside Reverse Transcriptase Inhibitor Resistance in HIV-1-Infected Patients: A Systematic Review and Meta-Analysis 2014 ·AIDS Research and Human Retroviruses ·Sonya J. Snedecor, Lavanya Sudharshan, (unknown), (unknown), Kit N. Simpson, Seema Haider, Richard Chambers, Charles Craig, Jennifer Stephens	12
15	Early Switch/Early Discharge Opportunities for Hospitalized Patients with Methicillin-Resistant Staphylococcus Aureus Complicated Skin And Soft Tissue Infections: Proof Of Concept in the United Arab Emirates 2014 ·Value in Health ·Ashraf El Houfi, (unknown), Dilip Nathwani, Caitlyn T. Solem, Cynthia Macahilig, Jennifer Stephens, (unknown), Petr Hájek, (unknown), Sajjad Haider	2
16	IN4 Health Care Resource Utilization (HCRU) and Costs among Patients Treated for Nosocomial Pneumonia (NP) Caused by Methicillin Resistant Staphylococcus Aureus (Mrsa): Secondary Analysis of a Multi-Center Randomized Controlled Study 2012 ·Value in Health ·Caitlyn T. Solem, Michael S. Niederman, Jean Chastre, (unknown), (unknown), Daniela E. Myers, Sajjad Haider, Richard Chambers, (unknown), Ben A. van Hout, Jennifer Stephens	4
17	Health economic review of recombinant activated factor VII for treatment of bleeding episodes in hemophilia patients with inhibitors 2007 ·Expert Opinion on Pharmacotherapy ·Jennifer Stephens, Ashish V. Joshi, Michael Sumner, Marc Botteman	10
18	HER-2 and cancer antigen 125 evaluation in ovarian borderline tumors by immunohistochemistry and fluorescence in situ hybridization 2004 ·International Journal of Gynecological Cancer ·(unknown), (unknown), (unknown), Susan A. Davidson, (unknown), Jennifer Stephens, M. Varella-Garcia	8
19	Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the United States 2002 ·Clinical Therapeutics ·Marc Botteman, Joseph A. Caprini, Jennifer Stephens, (unknown), Christopher F. Bell, Chris L. Pashos, Alexander T. Cohen	51
20	A short-term cost-of-treatment model for type 2 diabetes: comparison of glipizide gastrointestinal therapeutic system, metformin, and acarbose. 1999 ·PubMed ·Joe Ramsdell, (unknown), Jennifer Stephens, Marc Botteman, (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact